Melissa Burgess

Also affiliated with UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

New England Journal of Medicine(2023)10.1056/nejmoa2303383

N/A

3.3DataRank · unranked

158 citations

Elad Sharon, Geraldine O’Sullivan Coyne, Nancy Moore, Jared C. Foster, James Hu +26 more

Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11519

N/A

1.8DataRank · unranked

50 citations

Geraldine O’Sullivan Coyne, Nancy Moore, Elad Sharon, Naoko Takebe, Kristin Fino +15 more

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

B cells are associated with survival and immunotherapy response in sarcoma

Nature(2020)10.1038/s41586-019-1906-8

N/A

1.1DataRank · unranked

1962 citations

Aurélien de Reyniès, Emily Z. Keung, Tom Wei‐Wu Chen, Cheng‐Ming Sun, Julien Caldéraro +24 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0.807DataRank · unranked

216 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

The Oncologist(2025)10.1093/oncolo/oyaf362

N/A

0.307DataRank · unranked

6 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

medRxiv(2025)10.1101/2025.07.19.25331848

N/A

0.279DataRank · unranked

5 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

A phase 2 study of anti-PD-L1 antibody (atezolizumab) in grade 2 and 3 chondrosarcoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11528

N/A

0.208DataRank · unranked

3 citations

Anthony P. Conley, James Lin Chen, Elizabeth J. Davis, Melissa Burgess, Albiruni Ryan Abdul Razak +13 more

SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade Resistance

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3882

N/A

0.208DataRank · unranked

3 citations

Elina Mukherjee, David Ferraro, Shanthi Bhaskar, Anthony Green, E. Michael Meyer +6 more

A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11533

N/A

0.104DataRank · unranked

1 citations

Brian Ko, Brian A. Van Tine, Anthony P. Conley, Elizabeth J. Davis, Melissa Burgess +12 more

Data from Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

(2023)10.1158/1078-0432.c.6532980.v1

N/A

0DataRank · unranked

0 citations

Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica D. Daley, Cláudia Salgado +11 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

Data from Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

(2023)10.1158/1078-0432.c.6532980

N/A

0DataRank · unranked

0 citations

Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica D. Daley, Cláudia Salgado +11 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1471

N/A

0DataRank · unranked

89 citations

Elina Mukherjee, Nathanael G. Bailey, Sayali Onkar, Jessica D. Daley, Cláudia Salgado +11 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570

N/A

0DataRank · unranked

6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11531

N/A

0DataRank · unranked

1 citations

Shing M. Lee, Liner Ge, Mihaela Druta, Anthony P. Conley, Mary Louise Keohan +14 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506

N/A

0DataRank · unranked

11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more